CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT IN DIFFUSE LARGE B-CELL LYMPHOMA. A SINGLE CENTER ANALYSIS OF THE RISK FACTORS AND THE IMPACT OF CNS PROPHYLAXIS IN THE RITUXIMAB ERA

被引：0
|
作者：
Ansuinelli, M. [1 ]
Di Rocco, A. [1 ]
Fama, A. [2 ]
De Angelis, F. [1 ]
Maiuri, V. [1 ]
Minotti, C. [1 ]
Robin, F. [1 ]
Martelli, M. [1 ]
机构：
[1] Univ Roma La Sapienza, Inst Hematol, Dept Cellular Biotechnol & Hematol, Rome, Italy
[2] Arcispedale Santa Maria Nuova IRCCS, Hematol, Reggio Emilia, Italy
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E976
引用
收藏
页码：401 / 401
页数：1
相关论文
共 50 条
  • [41] Central nervous system involvement in adult patients with diffuse large B-cell lymphoma: Influence of rituximab
    Cao, Bing
    Zhou, Xiaoyan
    Ji, Dongmei
    Cao, Junning
    Guo, Ye
    Zhang, Qunling
    Wu, Xianghua
    Li, Junmin
    Wang, Jianmin
    Chen, Fangyuan
    Wang, Chun
    Zou, Shanhua
    Hong, Xiaonan
    ONCOLOGY LETTERS, 2012, 4 (03) : 541 - 545
  • [42] Risk Factors for Central Nervous System (CNS) Relapse after Autologous Stem Cell Transplant (ASCT) in Diffuse Large B-Cell Lymphoma (DLBCL)
    Terasaki, Yukie
    Shimizu, Hiroaki
    Miyazawa, Yuri
    Toyama, Kohtaro
    Koiso, Hiromi
    Yokohama, Akihiko
    Matsumoto, Morio
    Ogura, Hidemi
    Naito, Chiaki
    Tsukamoto, Norifumi
    Handa, Hiroshi
    BLOOD, 2019, 134
  • [43] Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era
    Takahashi, Hiroyuki
    Tomita, Naoto
    Yokoyama, Masahiro
    Tsunoda, Saburo
    Yano, Takahiro
    Murayama, Kayoko
    Hashimoto, Chizuko
    Tamura, Kazuo
    Sato, Kazuya
    Ishigatsubo, Yoshiaki
    CANCER, 2012, 118 (17) : 4166 - 4172
  • [44] Incidence and Risk Factors for Central Nervous System (CNS) Relapse In Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Analysis with Competing Risk Regression (CRR) Model
    Chihara, Dai
    Oki, Ysuhiro
    Matsuo, Keitaro
    Onoda, Hiroshi
    Taji, Hirofumi
    BLOOD, 2010, 116 (21) : 1691 - 1691
  • [45] A retrospective study at a single center examining risk factors associated with central nervous system involvement in individuals diagnosed with diffuse large B-cell lymphoma
    Chen, Wei
    Liu, Hu
    Hou, Shu-Ling
    Li, Xi
    Li, Li
    Lian, Ke
    Wu, Xiao-Bo
    Zhang, Xiao
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2024, 244
  • [46] CNS prophylaxis in diffuse large B-cell lymphoma: If, when, how and for whom?
    Siegal, Tali
    Goldschmidt, Neta
    BLOOD REVIEWS, 2012, 26 (03) : 97 - 106
  • [47] Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era
    Ferreri, Andres J. M.
    Bruno-Ventre, Marta
    Donadoni, Giovanni
    Ponzoni, Maurilio
    Citterio, Giovanni
    Foppoli, Marco
    Vignati, Alessandro
    Scarfo, Lydia
    Sassone, Marianna
    Govi, Silvia
    Caligaris-Cappio, Federico
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (05) : 654 - 662
  • [48] Effect of a rituximab-based regimen on the incidence of CNS relapse in patients with diffuse large B-cell lymphoma.
    Mahrous, M.
    Buckstein, R.
    Piliotis, E.
    Cheung, M. C.
    Berinstein, N. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] Primary extranodal diffuse large B-cell lymphoma in the rituximab era: a single center, retrospective analysis
    Zhao, Jinrong
    Zhang, Wei
    Zhou, Daobin
    HEMATOLOGY, 2022, 27 (01) : 757 - 764
  • [50] Real-World Application of the CNS-IPI in the Management of Central Nervous System Prophylaxis for Patients With Diffuse Large B-Cell Lymphoma and High- Grade B-Cell Lymphoma: A Single- Center Experience
    Kaplan, Lucas
    McLain, Julian
    Tun, Han
    Ali, Amir
    Tulpule, Anil
    Myint, Zaw Win
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S485 - S485
12345